Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
LUCIANA BORIO Insider Profile
11 Followers
LUCIANA BORIO, Director at Eagle Pharmaceuticals, holds ― shares in Eagle Pharmaceuticals (Ticker: EGRX), holds 2.28K shares in Insulet (Ticker: PODD). Most recently, LUCIANA BORIO ― shares of Eagle Pharmaceuticals on ― for an estimated value of ―.
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+27.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that LUCIANA BORIO holds in companies
Most Profitable Insider Trade
The most profitable trade made by LUCIANA BORIO
LUCIANA BORIO's Trading History
Eagle Pharmaceuticals
―
Director
―
―
Insulet
Dec 18, 2023
Director
Informative Sell
14.91K
$419.79K
List of latest transactions for each holding click on a transaction to see LUCIANA BORIO's performance on stock
You May Also Like
LUCIANA BORIO insider profile FAQ
What is the percentage of profitable transactions made by LUCIANA BORIO?
The percentage of profitable transactions made by LUCIANA BORIO is 100%.
What is the average return per transaction made by LUCIANA BORIO?
The average return per transaction made by LUCIANA BORIO is 27.80%.
What stocks does LUCIANA BORIO hold?
LUCIANA BORIO holds: EGRX, PODD stocks.
What was LUCIANA BORIO’s latest transaction?
LUCIANA BORIO latest transaction was an Uninformative Buy of ―.
What was LUCIANA BORIO's most profitable transaction?
LUCIANA BORIO’s most profitable transaction was an Informative Sell of PODD stock on June 6, 2023. The return on the trade was 38.90%.
What is LUCIANA BORIO's role in Eagle Pharmaceuticals?
LUCIANA BORIO's role in Eagle Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.